[Cardio-metabolic profile is influenced by modest modifications of body weight].

Service d'enseignement thérapeutique pour maladies chroniques, Centre collaborateur de l'OMS, Département de médecine communautaire, de premier recours et des urgences, HUG et Université de Genève 1211 Genève 14.
Revue médicale suisse 03/2012; 8(334):670-2.
Source: PubMed


Cardio-metabolic profile is influenced by modest modifications of body weight An increased body mass index (BMI) is associated with the metabolic syndrome (MS) and parameters composing it. There is a quasi linear relationship between BMI and number of MS components: an increase in BMI is associated with increasing number of cardio-metabolic alterations. This relationship exists not only in subjects with established obesity but also in those who are overweight or even have normal body weight. It has been also shown that a modest weight gain is associated with an increase in the number of MS components which, in turn, could contribute to the development of atherosclerosis. On the other hand, a modest weight loss is associated with decrease of MS components number and improvement of the cardio-metabolic profile.

Download full-text


Available from: Zoltan Pataky, Sep 08, 2015
2 Reads
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The purpose of the present longitudinal study was to describe the associations between the 5-year changes in body mass index (BMI) and alterations in the clusters of metabolic syndrome (MS)-related factors. The study population comprised 1099 middle-aged adults drawn from the Stanislas study. Individuals were stratified into four groups according to the 5-year changes in BMI (weight loss (<0 kg/m(2)), and weight gain (0-1, 1-2 and >2 kg/m(2))). Changes in various MS-related variables and clusters were compared between groups: anthropometric indices, blood pressure, lipid and inflammatory markers, liver enzymes, uric acid and the five summary factors extracted by using factor analysis ('risk lipids', 'liver enzymes', 'inflammation', 'protective lipids' and 'blood pressure'). There was a strong linear trend between increasing BMI and worsening of risk lipids and blood pressure factors for both men and women (P<or=0.001). In men only, liver enzymes and protective lipids factors were significantly related to the 5-year gain of BMI (P<or=0.001), whereas inflammation factor positively increased across the four BMI-change groups, in women only. Interaction terms for sex were statistically significant for inflammation and liver enzymes clusters. In our population, there was a strong linear trend between increasing BMI and worsening of various MS-related variables. More interestingly, the identification of five factors associated with BMI changes dependent to gender, support the hypothesis that weight gain, and probably obesity, trigger metabolic mechanisms that differ between men and women.
    International journal of obesity (2005) 08/2008; 32(8):1279-88. DOI:10.1038/ijo.2008.94 · 5.00 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: To investigate relationships between changes in weight and changes in cardiovascular risk factors in adults, taking intentionality of weight loss into account. Longitudinal study in middle-aged French subjects from the SU.VI.MAX cohort. A total of 1773 men (body mass index (BMI) 25.4+/-3.1 kg/m(2), mean+/-s.d) and 2316 women (BMI 23.3+/-3.8 kg/m(2)) aged 45 y and over at baseline. Weight, height, blood pressure, serum total cholesterol and fasting blood glucose were measured at baseline and after a 2 y follow-up. Self-reported dieting in order to lose weight, smoking status, leisure-time physical activity, health events and current treatments were assessed through questionnaires. In multivariate analyses, weight change was positively associated with changes in systolic and diastolic blood pressure (P=0.0002 in women, P=0.0001 in men) and with changes in serum total cholesterol (P=0.008 in women, P=0.02 in men), after adjustment for age, baseline level of each cardiovascular risk factor and current treatments. For example, in men, a weight loss of 5 kg was associated with a decrease of 2.5 mmHg in systolic blood pressure and of 1.5 mmHg in diastolic blood pressure. Taking into account self-reported dieting did not modify these associations. In both genders, systolic and diastolic blood pressure and serum cholesterol increased with weight gain and decreased with weight loss, independently of the intentionality to lose weight. At the population level, modest weight loss may have a substantial impact on cardiovascular risk, and preventing even modest weight gain in adults is an important goal in terms of public health.
    International Journal of Obesity 09/2002; 26(8):1138-43. DOI:10.1038/sj.ijo.0802059 · 5.00 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: How weight change affects the metabolic syndrome (MS) and its parameters is unknown, particularly, in a leaner European population such as the French prospective D.E.S.I.R. cohort. In 3770 D.E.S.I.R. participants (sex ratio=1) averaging 47.5 years (range 30-64), with measured weight and MS parameters at baseline (D0) and at 6 year follow-up (D6), we assessed this relationship across five weight-change classes, using stable weight as the referent group (-2 to +2 kg). We used analysis-of-covariance to assess changes in each MS parameter and logistic regression to assess incident MS, according to the National Cholesterol Education Program (NCEP). We also assessed weight-change effect on MS status between D0 and D6. At D0, average weight was 68.4 kg (SD 12.3); BMI was 24.8 kg/m2 (SD 3.5). From D0-D6, the cohort gained a mean 2.1 kg (median 2.0; SD 4.4). After adjustment for age and D0 weight, there was a strong linear relationship with weight change and worsening of the following MS parameters at D6: fasting insulin, waist girth, fasting glucose, fasting triglycerides, HDL cholesterol, and systolic and diastolic blood pressure (P<0.0001). After age adjustment, for every kilogram gained over 6 years, risk of developing the NCEP Syndrome increased 22% (OR 1.22; 95% CI 1.18-1.25). NCEP-MS was incident in 3% of those with stable weight compared with 21% among those gaining >9 kg; 10% of those who lost >2 kg reverted to non-NCEP-MS. All continuous MS measures are linearly related to weight change, and MS can resolve with modest weight loss, underscoring the importance of maintaining lifelong normal weight.
    International Journal of Epidemiology 03/2006; 35(1):190-6. DOI:10.1093/ije/dyi281 · 9.18 Impact Factor